迈普医学
(301033)
| 流通市值：27.38亿 | | | 总市值：32.49亿 |
| 流通股本：5605.86万 | | | 总股本：6651.94万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 41,795,654.28 | 32,033,529.88 | 49,380,615.16 | 26,676,610.18 |
| 应收票据及应收账款 | 11,596,244.33 | 13,895,171.13 | 14,073,639.85 | 18,077,156.28 |
| 应收账款 | 11,596,244.33 | 13,895,171.13 | 14,073,639.85 | 18,077,156.28 |
| 预付款项 | 2,949,629.52 | 3,424,741.2 | 3,776,692.68 | 4,576,292 |
| 其他应收款合计 | 1,662,386.01 | 1,581,678.23 | 1,496,065.55 | 1,294,854.17 |
| 存货 | 35,399,678.5 | 33,720,003.74 | 30,344,255.45 | 26,198,103.2 |
| 一年内到期的非流动资产 | 54,041,912.81 | 30,000,000 | - | - |
| 其他流动资产 | 121,998.31 | 260,469.61 | 30,787.53 | 70,144.89 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 285,882,172.38 | 227,575,931.84 | 265,898,793.41 | 269,712,417.33 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 2,349,757.17 | 2,266,278.53 | 2,265,802.37 | 2,265,802.37 |
| 其他非流动金融资产 | 28,000,000 | 28,000,000 | 28,000,000 | 28,000,000 |
| 投资性房地产 | 11,404,031.64 | 11,469,523.15 | 11,540,735.93 | 11,611,936.82 |
| 固定资产 | 310,511,680.01 | 313,350,363.07 | 312,856,506.26 | 316,866,145.24 |
| 在建工程 | 97,981.65 | - | 1,202,027.77 | 53,111.89 |
| 使用权资产 | 1,164,897.08 | 1,521,305.51 | 1,877,713.94 | 2,235,515.83 |
| 无形资产 | 64,800,853.56 | 66,516,320.28 | 68,261,472.54 | 70,006,624.8 |
| 开发支出 | 28,991,331.04 | 25,310,872.28 | 24,594,943.98 | 24,228,127.21 |
| 长期待摊费用 | 2,175,255.31 | 2,072,998.47 | 2,241,490.58 | 2,386,658.24 |
| 递延所得税资产 | 7,174,241.14 | 5,437,893.99 | 4,041,283.3 | 4,378,266.52 |
| 其他非流动资产 | 1,920,925.45 | 26,288,899.73 | 55,256,402.59 | 55,224,426.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 458,590,954.05 | 482,234,455.01 | 512,138,379.26 | 517,256,615.35 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 744,473,126.43 | 709,810,386.85 | 778,037,172.67 | 786,969,032.68 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 9,452,397.61 | 10,186,092.6 | 19,392,494.27 | 31,930,208.66 |
| 应付账款 | 9,452,397.61 | 10,186,092.6 | 19,392,494.27 | 31,930,208.66 |
| 预收款项 | 6,080,622.86 | 4,720,150.3 | 1,511,277 | 758,710.85 |
| 合同负债 | 692,883.39 | 1,588,269.31 | 1,246,846.28 | 438,624.04 |
| 应付职工薪酬 | 5,316,940.32 | 4,680,146.78 | 4,477,090.54 | 12,736,560.35 |
| 应交税费 | 10,383,086.14 | 9,456,513.74 | 12,760,430.65 | 13,613,653.67 |
| 其他应付款合计 | 11,850,694.49 | 2,518,063.57 | 2,257,212.71 | 2,905,825.9 |
| 一年内到期的非流动负债 | 1,315,975.69 | 1,613,922.6 | 5,709,520.33 | 5,689,407.32 |
| 其他流动负债 | 28,854.15 | 44,582.86 | 40,008.67 | 50,726.59 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 45,121,454.65 | 34,807,741.76 | 47,394,880.45 | 68,123,717.38 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 46,430,167.78 | 46,430,167.78 |
| 租赁负债 | 150,868.55 | 299,959.63 | 556,367.41 | 1,014,361.44 |
| 递延收益 | 35,629,498.06 | 36,952,949.09 | 38,785,205.09 | 35,283,439.39 |
| 递延所得税负债 | 301,727.24 | 253,836.59 | 313,449.4 | 259,133.28 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 36,082,093.85 | 37,506,745.31 | 86,085,189.68 | 82,987,101.89 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 81,203,548.5 | 72,314,487.07 | 133,480,070.13 | 151,110,819.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 66,062,951 | 66,062,951 | 66,062,951 | 66,062,951 |
| 资本公积 | 453,995,026.11 | 448,703,908.48 | 444,416,992.13 | 441,663,963.13 |
| 减:库存股 | 11,509,159.15 | 11,509,159.15 | 8,998,894.81 | - |
| 其他综合收益 | 1,246,284.71 | 1,176,020.74 | 1,175,619.96 | 1,175,619.96 |
| 盈余公积 | 12,939,995.52 | 12,939,995.52 | 12,939,995.52 | 12,939,995.52 |
| 未分配利润 | 140,534,479.74 | 120,122,183.19 | 128,960,438.74 | 114,015,683.8 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 663,269,577.93 | 637,495,899.78 | 644,557,102.54 | 635,858,213.41 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 663,269,577.93 | 637,495,899.78 | 644,557,102.54 | 635,858,213.41 |
| 负债和股东权益合计 | 744,473,126.43 | 709,810,386.85 | 778,037,172.67 | 786,969,032.68 |
| 公告日期 | 2024-10-29 | 2024-08-17 | 2024-04-25 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |